ÍÆ¼ö¸øºÃÓÑ ÉÏһƪ | ÏÂһƪ

×Ô·¢ÐÔÖëÍøÄ¤ÏÂÇ»³öѪ37ÀýÄÔѪ¹ÜÔìÓ°¼°Ñª¹ÜÄÚÖÎÁÆ·ÖÎö

[ÕªÒª] Ä¿µÄ  ÆÀ¼ÛÊý×Ö¼õÓ°ÄÔѪ¹ÜÔìÓ°£¨DSA£©ºÍѪ¹ÜÄÚÖÎÁÆ×Ô·¢ÐÔÖëÍøÄ¤ÏÂÇ»³öѪ(SAH)µÄÁÙ´²¼ÛÖµ¡£·½·¨ ×ܹ²37Àý×Ô·¢ÐÔSAH»¼Õß½øÐÐÁËDSA¼ì²é,ÆäÖÐ10ÀýÐÐѪ¹ÜÄÚÖÎÁÆ¡£½á¹û DSAÔìÓ°·¢ÏÖ¶¯ÂöÁö24Àý,¶¯¾²Âö»ûÐÎ(AVM) 3Àý;Á½Õß¼æÓÐ1Àý£¬MOYAMOYA²¡ 1Àý£¬8ÀýDSA¼ì²éÒõÐÔ¡£¶¯ÂöÁö»¼ÕßÖУºµ¥´¿µ¯»ÉȦ˨ÈûÊõ(7Àý),Ö§¼Ü¼Óµ¯»ÉȦÊõ(1Àý),µ¥´¿Ö§¼ÜÊõ(1Àý).1Àý AVM»¼Õß½ÓÊÜÁËNBCA½ºË¨Èû£¬¾ù³É¹¦¡£½áÂÛ DSAÊÇÃ÷È·×Ô·¢ÐÔSAHÔ­ÒòµÄ¿É¿¿·½·¨,Ѫ¹ÜÄÚÖÎÁÆÊÇÖÎÁƶ¯ÂöÁöºÍ¶¯¾²Âö»ûÐεÄÓÐЧ·½·¨¡£

[¹Ø¼ü´Ê]ÖëÍøÄ¤ÏÂÇ»³öѪ£»ÄÔѪ¹ÜÔìÓ°£»Ñª¹ÜÄÚÖÎÁÆ£»¶¯¾²Âö»ûÐÎ

The analysis of endovascular therapy and cerebral Angiography in spontaneously Subrachnoid Hemorrhage Shi Qin-Sheng  Zhang-Peng  Ma Geng-Ping  Wang-Fei  Hu Yue-Feng Kang Quan-Li  Feng Kai£»Beijing Shunyi District Hospital£¬Xuanwu Hospital of Capital University of Medical Sciences

[Abstract] Objective To evaluate  the clinic value of digital subtraction angiography(DSA) and endovascular therapy in spontaneous subarachnoid hemorrhage(SAH).Methods Total 37 patients with spontaneous SAH were performed by DSA, 10 cases were treated with endovasclar therapy. Results DSA showed aneurysm in 24 cases; arteriovenus malformation(avm) in 3; one case with both aneurysm and AVM; one case with MOYAMOYA; 9 cases were negative. Of aneurysms patiens, embolization with coils in 7; embolization with coils and supporting stent in 1 case; only implantation of stent in 1case. One AVM patient was embolized with NBCA. Conclusion DSA is a reliable methoed for aetiological diagnosis of SAH; Endovascular therpy is an effective mothod to treat aneurysms and AVM.

[Key words]Spontaneously Subrachnoid Hemorrhage(SAH);Cerebral Angiography; Endovascular Therapy; Arteriovenus Malformation(AVM);

¡¡ÖëÍøÄ¤ÏÂÇ»³öѪ(SAH)ΪÁÙ´²³£¼ûµÄÎ£ÖØÄÔѪ¹Ü²¡,Äê·¢²¡ÂÊΪ10.5/10Íò[1],ÆäÖÂËÀÂʼ°É˲ÐÂʽϸߡ£Æä×î³£¼ûµÄ²¡ÒòÊÇ­µ×ÄÒÐÔ¶¯ÂöÁöÆÆÁÑ,AVMºÍ¸ßѪѹ¶¯ÂöÓ²»¯µÈ¡£¾­¹É¶¯Âö´©´ÌÊý×Ö¼õÓ°È«ÄÔѪ¹Ü³ÉÏñ¼¼Êõ(DSA)±»ÈÏΪÊÇÕï¶Ï¶¯ÂöÁöµÄ½ð±ê×¼[2]£¬¶øÑª¹ÜÄÚ½éÈëÖÎÁÆÊÇÌá¸ß×Ô·¢ÐÔSAHÖÎÓúÂʵÄÖØÒªÊÖ¶ÎÖ®Ò»¡£±¾ÎĶÔ2004Äê12ÔÂÖÁ2007Äê10Ô¼äÎÒÔº½øÐÐDSAÔìÓ°Õï¶ÏºÍѪ¹ÜÄÚ½éÈëÖÎÁƽá¹û½øÐб¨µÀ¡£
×ÊÁϺͷ½·¨

1¡¢ Ò»°ã×ÊÁÏ
2004Äê12ÔÂÖÁ2007Äê10Ô¼äÎÒÔº½øÐÐÄÔѪ¹ÜÔìÓ°Õï¶ÏµÄSAH 37Àý¡£ÄÐ26Àý(70.3%),Å®11Àý(29.7%),ÄÐÅ®±ÈÀýΪ2.36¡Ã1¡£ÄêÁä14¡«74Ëê,ƽ¾ù49.1Ëê,30¡«60ËêÕß28ÀýÕ¼75.7%¡£Õï¶Ï¸ù¾ÝÁÙ´²±íÏÖ¼°Í·Â­CTºÍÑü´©½á¹û¡£ËùÓл¼Õß½øÐÐDSA¼ì²éǰ¾ùÐÐͷ­£Ã£ÔɨÃè,37Àý±íÏÖΪ²àÁѳء¢°°Éϳء¢×ÝÁѵȲ¿Î»¸ßÃܶȳöѪӰÏñ,ºÏ²¢ò¨Ò¶ÑªÖ×2Àý¡£

2¡¢ ·½·¨
2.1ÄÔѪ¹ÜÔìÓ°£º²ÉÓÃѪ¹ÜÔìÓ°»úÊÇPHILIPS ALLURA£¬Ñª¹ÜÔìÓ°²ÉÓÃSeldinger¼¼Êõ¾­ÓÒ²à¹É¶¯Âö´©´Ì²å¹Ü,ÔìÓ°¼ÁΪµâº£´¼£¬Ó¦ÓÃDSAÉ豸½øÐÐÓ°Ïñ´¦Àí,³£¹æË«²à¾±×ܶ¯Âö¡¢Ë«²à×µ¶¯ÂöÕý²àбλÔìÓ°,±ØÒªÊ±ÐÐÐýתÔìÓ°ºÍ¶à½Ç¶ÈͶÕÕ,¶ÔÓÚ¿ÉÒɶ¯¾²Âö»ûÐεϼÕß¼ÓË«²à¾±Í⶯ÂöÔìÓ°¡£37Àý²¡ÈËÔÚ·¢²¡ºó8£è¡«2ÖÜÄÚ½øÐÐÊ×´ÎDSA¼ì²é,2ÀýÓÚÊ×´ÎDSA¼ì²é½á¹ûÒõÐÔ2ÖÜÄÚ¸øÓèCTA»òÖØ¸´ÄÔѪ¹ÜÔìÓ°¡£
2.2½éÈëÖÎÁÆ·½·¨: ±¾×é¹²½øÐнéÈëÖÎÁÆ10Àý£¬ÆäÖÐ7ÀýÕ­¾±¶¯ÂöÁö»¼Õß½øÐе¥´¿µ¯»ÉȦ˨Èû£¬1Àý»ùµ×¶¯Âö¶¥¶Ë¶¯ÂöÁöÐÐneruformÖ§¼ÜÁªºÏµ¯»ÉȦ˨Èû£¬1Àý¾±ÄÚ-ºó½»Í¨¿í¾±¶¯ÂöÁöÐе¥´¿neruformÖ§¼Ü£¬1Àýò¨Ò¶AVM½øÐÐNBCA½ºË¨Èû¡£

½á     ¹û
1¡¢ ÄÔѪ¹ÜÔìÓ°¼ì²é¡¡DSAÔìÓ°37Àý, ÆäÖЭÄÚ¶¯ÂöÁö24Àý£¨64.8%£©(Ïê¼û±í1),AVM 2Àý(5.4 %),¶¯ÂöÁöºÏ²¢¶¯¾²Âö»ûÐÎ1Àý£¨2.7%£©£¬MOYAMOYA²¡ 1Àý(2.7 %),ÄÔѪ¹ÜÔìÓ°´óÖÂÕý³£ 8Àý£¨21.6%£©¡£ºÏ²¢ÄÔѪ¹Ü¾·ÂεĹ²6Àý¡£
±í1  24Àý¶¯ÂöÁöÏêϸÇé¿öÁбí

±í1 24Àý¶¯ÂöÁöÏêϸÇé¿öÁбí

¶¯ÂöÁö·ÖÐÍ

ÀýÊý

Õ¼¶¯ÂöÁöµÄ±ÈÀý£¨%£©

¾±ÄÚ-ºó½»Í¨Ö§¶¯ÂöÁö

9

37.5

ǰ½»Í¨¶¯ÂöÁö

7

29.20

        ¾±ÄÚ¶¯Âö·Ö²æ²¿¶¯ÂöÁö

1

4.20

´óÄÔÖж¯Âö·Ö²æ²¿¶¯ÂöÁö

3

12.5

 Ð¡ÄÔºó϶¯ÂöÁö

1

4.20

»ùµ×¶¯Âö¶¥¶Ë¶¯ÂöÁö

1

4.20

¶à·¢¶¯ÂöÁö

2

8.30

       ÁíÍ⶯ÂöÁöºÏ²¢¶¯¾²Âö»ûÐΣ¨Î´¼ÆÈë×ÜÊý£©

1

 

ÔÚ24Àý¶¯ÂöÁöÖУºÎ¢ÐÍ(£¼3mm):6¸ö; СÐÍ(3-6mm)£º14Àý£»ÖÐÐÍ(6-12mm)£º3Àý;¾Þ´ó(25-35mm):1Àý¡£¿í¾±£º3Àý£»ËóÐÍ£º2Àý£»Õ­¾±£º19Àý¡£×¡ÔºÆÚ¼ä3Àý»¼ÕßËÀÍö¡£

2¡¢ ½éÈëÖÎÁƽá¹û£º
±í2   ½éÈëÖÎÁƽá¹û£¨ÀýÊý£©

±í2  ½éÈëÖÎÁƽá¹û£¨ÀýÊý£©

¡¡

¡¡ÖÎÁÆ·½·¨

ÀýÊý

Íêȫ˨Èû

´ó²¿·Ö˨Èû

 

¶¯ÂöÁö

GDC

7

5

2

 

 

NeruformÖ§¼Ü+GDC

1

 

1

 

 

µ¥´¿NeruformÖ§¼Ü

1

 

 

 

ò¨Ò¶AVM

NBCAÕ³¶Â

1

1

¡¡

 

 

 


 

ÔÚÉÏÊö37Àý»¼ÕßÖÐ10Àý²ÉÈ¡Á˽éÈëÖÎÁÆ£¨Ïê¼û±í2£©£¬ÆäÖÐ1Àý¶¯ÂöÁöÔÚ˨Èû¹ý³ÌÖо±ÄÚ¶¯ÂöÄÚѪ˨Ðγɣ¬¼±ÕïÈÜ˨£¬ÔÚÈÜ˨¹ý³ÌÖж¯ÂöÁöÆÆÁѳöѪÁ¢¿ÌÐÐGDC˨Èûºó³öѪֹͣ£»1Àý½¥³¤´óµÄ¶¯ÂöÁöλÓÚ¾±ÄÚ-ºó½»Í¨-´óÄԺ󽻽紦£¬Ë¨Èûºó´óÄÔºó¶¯Âö±ÕÈû£¬µ«´ú³¥Á¼ºÃ£»ò¨Ò¶AVM˨Èûºó¼´¿Ì³öÏÖÒ»¹ýÐÔñ²ðï¡£ËùÓл¼Õß¾­Ëæ·Ã¾ù½¡ÔÚ£¬¾ùÎÞÃ÷ÏÔ¹¦ÄÜÕϰ­¡£    
      
ÌÖ       ÂÛ                                                                                                          
­ÄÚ¶¯ÂöÁöÊÇSAH×î³£¼ûµÄ²¡Òò,ÆäËûÔ­ÒòÓиßѪѹ¡¢¶¯ÂöÖàÑùÓ²»¯¡¢ÄÔѪ¹Ü»ûÐΡ¢·Ç¶¯ÂöÁöÐÔÖÐÄÔÖÜΧ³öѪ¡¢¶¯Âö¼Ð²ã·ÖÀë¡¢MOYAMOYA²¡µÈ[3]¡£±¾×é37Àý×Ô·¢ÐÔÖëÍøÄ¤ÏÂÇ»³öѪµÄ»¼ÕßÖУ¬Ã÷È·Õï¶Ï²¡ÒòµÄ¹²¼Æ28Àý£¨75.7%£©£¬ÆäÖЭÄÚ¶¯ÂöÁö24Àý£»AVM 2Àý£»¶¯ÂöÁöºÏ²¢¶¯¾²Âö»ûÐÎ1Àý£»MOYAMOYA²¡ 1Àý,ºÏ²¢ÄÔѪ¹Ü¾·ÂÎ6Àý¡£¾Ý¹úÍâÎÄÏ×±¨µÀ,­ÄÚ¶¯ÂöÁöÔ¼Õ¼SAHµÄ85%[4-6]£¬ÔÚ±¾Ñо¿ÖÐ,¶¯ÂöÁö»¼ÕßÖ»ÓÐ64.9%,µÍÓÚ¹úÍⱨµÀ¡£
ÁíÍâÄÔѪ¹ÜÔìÓ°ÒõÐÔ8Àý¡£ÐèҪ˵Ã÷µÄÊÇ24Àý¶¯ÂöÁö»¼ÕßÖÐÓÐ1Àý»¼ÕßÄÔѪ¹ÜÔìÓ°Ê״ΩÕ¶øËæºóCTAºÍ½éÈëÖÎÁÆÊ±ÄÔѪ¹ÜÔìӰ֤ʵΪһ¸öÖ±¾¶2ºÁÃ×µÄ΢С¶¯ÂöÁö³¤´ó³ÉΪһ¸öÖ±¾¶1¹«·ÖµÄÖÐÐͶ¯ÂöÁö£¬Ê״ΩÕïµÄÔ­ÒòΪ¶¯ÂöÁö΢С²¢ÓëÖÜΧѪ¹ÜÖØµþ±»ÎóÈÏΪѪ¹ÜÓØÇúËùÖ¡£´Ë»¼ÕßͬʱҲÌáʾ¶¯ÂöÁö˨ÈûºóÔÙ³öѪ»¼ÕßÖУ¬¶¯ÂöÁöÔö´ó¿ÉÄÜÊÇÔÙ³öѪµÄÔ­ÒòÖ®Ò»¡£¶ø1ÀýѪ¹ÜÔìÓ°ÒõÐÔ»¼ÕßסԺÆÚ¼äÔÙ³öѪËÀÍö£¬ÁÙ´²ÈÔÈ»¿¼ÂÇΪ¶¯ÂöÁöÆÆÁѳöѪ£¬ÌáʾѪ¹ÜÔìÓ°ÒõÐÔ¸üÓ¦µ±Ìá¸ß×¢Òâ¡£×ܽáÒõÐÔµÄÔ­ÒòÈçÏ£º¿ÉÄÜÊǸßѪѹ²¡¡¢¶¯ÂöÁöѪ˨Ðγɡ¢³öѪºóѪ¹Ü¾·ÂÎ ¡¢ÒþÄäÐÔѪ¹Ü»ûÐΡ¢Ö×Áö×äÖС¢Î¢Ð¡¶¯ÂöÁö[7]¡¢ÓëѪ¹ÜÖØµþ¼°ÔìÓ°µÄ¼¼ÊõÉ豸ËùÖ¡£ËùÒÔ¶ÔÓÚÔìÓ°ÒõÐÔµÄSAH»¼Õ߸üÓ¦ÌØ±ðÁôÒâ:´Ó¼¼ÊõÉϽøÐжàÌåλµÄÔìÓ°¡¢2ÖÜÄÚÖØ¸´ÄÔѪ¹ÜÔìÓ°¡¢3DµÄÓ¦Óü°CTA¸´²é¡¢¼¯Ìå¶ÁƬÄÜÓÐÖúÓÚ¼õÉÙ©ÕïµÄ·¢Éú£»Âé×íµÄÓÐЧÅäºÏÄÜÃ÷ÏÔµÄÔö¼ÓÓ°ÏñµÄÖÊÁ¿ºÍ°²È«ÐÔ¡£ÁíÍâÎÄÏ×Ò²ÌáʾѪ¹ÜÔìÓ°ÒõÐԵϼÕßÓ¦µ±×¢Ò⣻¼ì²éÓ²ÄÔĤ¶¯¾²ÂöðüÏòƤ²ãÒýÁ÷£»¾±ÄÚ¶¯Âöº£Ãàñ¼ðüÏòÄÔÆ¤²ã¾²ÂöÒýÁ÷;¼¹ËèµÄ¶¯¾²Âö»ûÐΡ£±ØÒªÊ±¿ÉÐо±ÍâϵͳÔìÓ°¼°¼¹ËèѪ¹ÜÔìÓ°¼ì²é[7]¡£
ÄÔ³öѪºóÖØÒªµÄ²¢·¢Ö¢ÓÐÁ½¸ö¡ª¡ªÔÙ³öѪºÍÑÓ³ÙÐÔȱѪÐÔÉñ¾­¹¦ÄÜÕϰ­(NIND) [8]¡£±¾×éÔÚסԺÆÚ¼äËÀÍö3Àý´ÓÁÙ´²¿¼ÂǾùΪÔÙ³öѪËùÖ¡£ÔÙ³öѪ¿ÉÒòÅű㡢¿ÈËÔ¡¢ÇéÐ÷¼¤¶¯¡¢¹ýÔç»î¶¯¡¢Òò¾­¼ÃÔ­Òò²»Äܾ¡¿ìÃ÷È·²¡Òò²¢²ÉÈ¡»ý¼«ÓÐЧµÄÖÎÁÆÊֶΡ¢ ²¡ÇéÑÏÖØ²¢ÇÒ¸´ÔÓÀ´²»¼°²ÉÈ¡ÓÐЧµÄÖÎÁÆ´ëÊ©µÈÒòËØÒýÆð;NINDÊÇSAHºóÒ»ÖÖ×ÛºÏÕ÷£¬Æä²¡Òò°üÀ¨Ñª¹Ü¾·ÂΣ¬ÄÔË®Ö×£¬ÄÔÖ×ÕÍ£¬ÄÔ»ýË®£¬ÐÄÊä³öÁ¿¼õÉÙ£¬ÍÑË®£¬ÑªÒºÕ³³í¶ÈÔö¼Ó£¬È±ÑªãÐÖµ½µµÍµÈ¡£Ñª¹Ü¾·Âα»ÈÏΪÊÇÒ»¸ö×îÖØÒªµÄÔ­Òò£¬±¾×éDSA·¢ÏÖ6Àý»¼ÕßÄÔѪ¹Ü¾·ÂΣ¬¶ÔÓÚÄÔѪ¹Ü¾·Âλ¼Õߣ¬Á¢¼´¿ªÊ¼¾²ÂöµÎ×¢ÄáĪµØÆ½¼°ÓèÒÔÀ©ÈÝ¡¢Éýѹ¡¢Ï¡ÊÍѪҺµÄÖÎÁÆ¡£
½éÈëÉñ¾­·ÅÉäѧµÄ·¢Õ¹ÎªÂ­ÄÚ¶¯ÂöÁöµÄÖÎÁÆ¿ª±ÙÁËеÄÓÐЧ;¾¶¡£Ó°ÏìѪ¹ÜÄÚ˨ÈûÊõµÄÖ÷ÒªÒòËØÎª¶¯ÂöÁöµÄ´óСºÍÌå¾±±È£¬±¾×éµÄÍêȫ˨ÈûºÍ´ó²¿·Ö˨Èû±ÈÀý½Ï¸ß¿ÉÄܺÍÖÐСÐÍÕ­¾±¶¯ÂöÁö±ÈÀý½Ï¸ßÓйء£¶ø»¼ÕßÔ¤ºóÁ¼ºÃ¿ÉÄܺͱ¾×黼Õß¾ùΪHunt-Hess·Ö¼¶I-¢ó¼¶ÇÒÔçÆÚ˨ÈûÓйأ¬µ±È»Êõºó¼°Ê±ÓÐЧµÄÁÙ´²´¦ÀíÒ²Æð׏ؼüµÄ×÷Óᣱ¾×éÒ»ÀýÑÏÖØ²¢·¢Ö¢Îª²Ù×÷¹ý³ÌÖо±ÄÚ¶¯ÂöÃÖÂþ¼±ÐÔѪ˨Ðγɣ¬¼´¿Ì¸øÓèÄò¼¤Ã¸25Íòµ¥Î»µ¼¹ÜÄÚÈÜ˨ºóÏÔʾ¾±ÄÚ¶¯ÂöÖ÷¸É¼°´óÄÔǰ¼°²¿·Ö´óÄÔÖж¯Âö·ÖÖ§ÏÔÓ°£¬¶øºóÓÃ΢µ¼¹Ü¼¼Êõ½øÐг¬Ñ¡ÔñÈÜ˨¹ý³ÌÖУ¬Äò¼¤Ã¸ÓÃÁ¿Ô¼70Íòµ¥Î»Ê±·¢ÏÖºó½»Í¨¶¯ÂöÁöÆÆÁѳöѪ£¬¼±Õï½øÐе¯»ÉȦ˨Èûºó³öѪֹͣ¡£·ÖÎö¶¯ÂöѪ˨µÄÔ­Òò¿ÉÄܺ͵¼¹Ü³¤Ê±¼äµÄ´Ì¼¤¼°SAHºó¼¤»î³öÄýѪ»úÖÆÓйء£¶ø±¾×黼ÕßÔ¤ºóÁ¼ºÃ˵Ã÷­ÄÚ¶¯ÂöÁö²ÉÈ¡µ¥´¿µç½âÍѲ¬Î¢µ¯»ÉȦ£¨GDC£©¡¢Ö§¼Ü¼Óµ¯»ÉȦ¼°µ¥´¿Ö§¼ÜÖÎÁƼ¼ÊõÊÇÖÎÁƶ¯ÂöÁöµÄÓÐЧ·½·¨Ö®Ò»¡£
×ÛÉÏËùÊöSAH³öѪԭÒò¸´ÔÓ£¬ÄÔѪ¹ÜÔìÓ°ÄÜÃ÷È·´ó²¿·ÖSAH²¡Òò£¬¶Ô¶¯ÂöÁö»¼ÕßÄÜÃ÷È·¶¯ÂöÁöµÄλÖᢴóС£¬ÐÎ×´£¬ÊÇ·ñ¿í¾±µÈÇé¿ö£¬¶ÔÖ¸µ¼Ñ¡ÔñºÏÊʵÄÖÎÁÆ·½°¸¼°Êõºó´¦ÀíÓÐ×ÅÖØÒªµÄ×÷Ó᣶ø½éÈëÖÎÁƶ¯ÂöÁöºÍ¶¯¾²Âö»ûÐξßÓÐ΢´´¡¢»Ö¸´¿ìµÈÓŵ㣬ֵµÃÍÆ¹ã¡£

²Î ¿¼ ÎÄ Ï×
1 Linn FH, Rinkel GJ, Algra A, et al. Incidence of subarachnoid hemorrhage: role o fregion, year, and rate of computed to mography: a meta-analysis[J].Stroke,1996,27(4):625-629.
2 Cloft  HJ, Joseph GJ, Dion JE .Meta-analysis of  risks  of  cerebral  angiography in  patients  with  subarachnoid hemorrhage, intracranial aneurysm and arteriovenous malformation[J] . Stroke,1999,30:317-320.
3 ÂíÁ®Í¤£¬ÓàÔó£¬Ðì¹úÕþ£¬µÈ.Ö÷±à.½éÈëÉñ¾­Íâ¿ÆÑ§.Î人£ººþ±±¿ÆÑ§¼¼Êõ³ö°æÉ磬2003.1
4 Gijn J, Dongen KJ. Computerized to mography in subarachnoid hemorrhage: difference between patients with and without an aneurysm on angiography[J].Neurology,1980,30(5):538-539.
5 Kassel NF, Torner JC, Jane JA, et al. The international cooperative study on the timing of aneurysm surgery part2:surgicalresults[J].Neurosurgery,1990,73(1):37-47.
6 Velthuis BK, Rinkel GJ, Ramos LM, et al. Subarachnoid hemorrhage: aneurysm detection and preoperative evaluation with CT angiography[J].Radiology,1998,208(2):423-430.
7 ]ÐìÄþ£¬ÍõºêÀÚ£¬ÂÞì÷£¬µÈ.ÖëÍøÄ¤ÏÂÇ»³öѪ506ÀýÁÙ´²·ÖÎö[J].¼ªÁÖ´óѧѧ±¨£¬2004£¬30£º138-140.
8 ë²®£¬ÕÅÔ¾¿µ£¬Õź㣬µÈ.¶¯ÂöÁöÊõºóѪ¹Ü¾·ÂεÄ×ÛºÏÖÎÁÆ£¨¸½284Àý±¨¸æ£©[J].Öйú΢´´.ÇÖÏ®Éñ¾­Íâ¿ÆÔÓÖ¾£¬2004£¬9£¨2£©£»53-56





TAG: ÖëÍøÄ¤ÏÂÇ»³öѪ ÄÔѪ¹ÜÔìÓ° Ѫ¹ÜÄÚÖÎÁÆ ¶¯¾²Âö»ûÐÎ
 

ÆÀ·Ö£º0

ÎÒÀ´ËµÁ½¾ä

seccode